There are over 20 identified gut peptides within the GI tract, many of which play a key role in energy and glucose homeostasis, with the following sections focusing on the incretin hormones GLP-1 and glucose-dependent insulinotropic polypeptide (GIP), CCK, and several others
For instance, a comprehensive study published in Obesity Reviews indicated that without structured dietary and exercise interventions, individuals on GLP-1 medications experienced muscle loss comprising up to nearly half of their total weight loss (Wilding et al., 2021)
I have read mixed results of BPC 57, so I am curious of how your results will pan out
With a proven track record of meeting the growing needs of the cardiometabolic market, SHLs Molly autoinjectors are poised to usher in a new era in cardiometabolic care
The question, as always, is whether these drugs actually work well enough to justify the comparison